NTRK1 and obstructive sleep apnea syndrome: The authors therefore concluded that given the relatively high and uniform expression of TrkA in canine OSA, as well as the induction of apoptosis in canine OSA cell lines after signaling blockade, TrkA could potentially serve as a novel therapeutic target in dogs diagnosed with OSA.